Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) Research & Development (2016 - 2025)

Innoviva's Research & Development history spans 14 years, with the latest figure at $9.4 million for Q3 2025.

  • For Q3 2025, Research & Development rose 164.71% year-over-year to $9.4 million; the TTM value through Sep 2025 reached $25.3 million, up 81.21%, while the annual FY2025 figure was $30.6 million, 124.14% up from the prior year.
  • Research & Development reached $9.4 million in Q3 2025 per INVA's latest filing, up from $8.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $15.0 million in Q2 2023 to a low of $38000.0 in Q2 2021.
  • Average Research & Development over 5 years is $6.4 million, with a median of $4.4 million recorded in 2025.
  • Peak YoY movement for Research & Development: plummeted 93.2% in 2021, then soared 36436.84% in 2022.
  • A 5-year view of Research & Development shows it stood at $449000.0 in 2021, then skyrocketed by 2511.36% to $11.7 million in 2022, then tumbled by 65.98% to $4.0 million in 2023, then fell by 10.98% to $3.6 million in 2024, then soared by 164.71% to $9.4 million in 2025.
  • Per Business Quant, the three most recent readings for INVA's Research & Development are $9.4 million (Q3 2025), $8.0 million (Q2 2025), and $4.4 million (Q1 2025).